5-Bromo-4-methyl-1H-indole-2-carbonitrile – (1857296-19-5)

Fruquintinib, 1194506-26-7, HMPL-013, Fruzaqla, HMPL013, Fruquintinib [WHO-DD], Fruquintinib [USAN], 6-(6, 7-dimethoxyquinazolin-4-yl)oxy-N, 2-dimethyl-1-benzofuran-3-carboxamide, fruquintinibum, Elunate, UNII-49DXG3M5ZW, 49DXG3M5ZW, 6-[(6, 7-dimethoxyquinazolin-4-yl)oxy]-N, 2-dimethyl-1-benzofuran-3-carboxamide, FRUQUINTINIB [INN], 6-((6, 7-dimethoxyquinazolin-4-yl)oxy)-N, 2-dimethylbenzofuran-3-carboxamide, 6-(6, 7-dimethoxyquinazolin-4-yloxy)-N, 2-dimethylbenzofuran-3-carboxamide, GTPL9428, 3-Benzofurancarboxamide, 6-((6, 7-dimethoxy-4-quinazolinyl)oxy)-N, 2-dimethyl-, 6-[(6, 7-Dimethoxy-4-quinazolinyl)oxy]-N, 2-dimethyl-3-benzofurancarboxamide, 6-((6, 7-dimethoxyquinazolin-4-yl)oxy)-N, 2-dimethyl-1-benzofuran-3-carboxamide, Fruzaqla (TN), Fruquintinib (Standard), Fruquintinib (JAN/USAN), Fruquintinib HMPL-013, Fruquintinib (HMPL-013), Fruquintinib (HMPL-013)?, SCHEMBL947183, Fruquintinib [USAN:WHO-DD], HMPL 013, CHEMBL4303214, BALLNEJQLSTPIO-UHFFFAOYSA-N, CHEBI:229221, BCP15692, EX-A2262, HY-19912R, NSC801000, NSC829498, s5667, WHO 10348, AKOS026750586, CCG-268573, CS-5558, DB11679, NSC-801000, NSC-829498, SB17123, VEGFR-1/2/3 Inhibitor HMPL-013, NCGC00481603-01, AS-73141, FF137674, HMPL-013 HMPL013 HMPL 013, HY-19912, NS00073373, C71641, D11977, BRD-K70504253-001-01-3, Q27259271